Bayer Aktiengesellschaft (ETR:BAYN)
36.62
-1.76 (-4.59%)
Apr 28, 2026, 5:36 PM CET
Bayer Aktiengesellschaft Revenue
In the year 2025, Bayer Aktiengesellschaft had annual revenue of 45.58B EUR, down -2.21%. Bayer Aktiengesellschaft had revenue of 11.44B in the quarter ending December 31, 2025, a decrease of -2.48%.
Revenue
45.58B
Revenue Growth
-2.21%
P/S Ratio
0.79
Revenue / Employee
522.17K
Employees
87,280
Market Cap
35.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 45.58B | -1.03B | -2.21% |
| Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
| Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
| Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
| Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck KGaA | 21.10B |
| Siemens Healthineers AG | 23.30B |
| Fresenius SE & Co. KGaA | 22.87B |
| Sartorius Aktiengesellschaft | 3.55B |
| Fresenius Medical Care AG | 19.63B |
| Ottobock SE & Co. KGaA | 1.68B |
| Fielmann Group AG | 2.42B |
| SCHOTT Pharma AG & Co. KGaA | 995.03M |
Bayer Aktiengesellschaft News
- 20 hours ago - Bayer shares slide after U.S. Supreme Court split over Bayer's fight against Roundup lawsuits - Reuters
- 1 day ago - With Bayer at US Supreme Court, MAHA rallies against pesticides - Reuters
- 1 day ago - US Supreme Court hears Bayer's fight against Roundup lawsuits - Reuters
- 2 days ago - Explainer: What does Bayer's US Supreme Court case mean for the thousands of Roundup lawsuits? - Reuters
- 8 days ago - The Cancer Victims Who Could Sink Bayer's Roundup Settlement - WSJ
- 11 days ago - US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims - Reuters
- 11 days ago - U.S. judge rejects Bayer's bid to block Johnson & Johnson prostate cancer drug claims - Reuters
- 13 days ago - Bayer Canada Supports New School of Medicine at Simon Fraser University (SFU) With Full Tuition Entrance Award for Inaugural Class - Business Wire